The World Health Organization (WHO) today announced it had invited mpox vaccine manufacturers to submit an Expression of Interest for Emergency Use Listing (EUL).
On August 9, 2024, the WHO stated that the EUL procedure is an emergency use authorization process specifically developed to expedite the availability of unlicensed medical products, such as vaccines, needed in public health emergencies.
This is a time-limited WHO recommendation based on a risk-benefit approach.
Read More
